Filed: 2/14/2024ACC: 0001123292-24-000048
📋 What this filing means
ATHYRIUM CAPITAL MANAGEMENT, LP filed this quarterly 13F‑HR report disclosing 3 equity positions with a total reported market value of $68.83M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
3
Positions
$68.83M
Total AUM (reported)
85.70M
Total Shares
Allocation by class
NOTE 5.250% 2/1$46.31M67.3%
COM NEW$14.76M21.4%
COM$7.76M11.3%
Portfolio Concentration
Top 3$68.83M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 85.70M
Sole
Full voting authority
12.72M
shares
% of voting shares14.8%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
72.98M
shares
% of voting shares85.2%
Investment Discretion (by position count)
Sole3
Shared0
Other0
Dominant voting typeNone · 85.2% of voting shares
Institutional Holdings3
Rows:
Omeros Corp
SOLEShares72.98M
TypePRN
Market value$46.31M
67.29%
Sole
0.00
Shared
0.00
None
72.98M
Biora Inc.
SOLEShares10.93M
TypeSH
Market value$14.76M
21.44%
Sole
10.93M
Shared
0.00
None
0.00
PUMA BIOTECHNOLOGY INC
SOLEShares1.79M
TypeSH
Market value$7.76M
11.27%
Sole
1.79M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Omeros CorpSOLE | NOTE 5.250% 2/1 | 72.98M | PRN | $46.31M 67.29% | 0.00 | 0.00 | 72.98M |
Biora Inc.SOLE | COM NEW | 10.93M | SH | $14.76M 21.44% | 10.93M | 0.00 | 0.00 |
PUMA BIOTECHNOLOGY INCSOLE | COM | 1.79M | SH | $7.76M 11.27% | 1.79M | 0.00 | 0.00 |